242 related articles for article (PubMed ID: 25551591)
41. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
43. Adjunct screening of cervical or vaginal samples using careHPV testing with Pap and aided visual inspection for detecting high-grade cervical intraepithelial neoplasia.
Asthana S; Labani S
Cancer Epidemiol; 2015 Feb; 39(1):104-8. PubMed ID: 25548076
[TBL] [Abstract][Full Text] [Related]
44. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
[TBL] [Abstract][Full Text] [Related]
45. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus DNA and mRNA prevalence and association with cervical cytological abnormalities in the Irish HIV population.
Loy A; McInerney J; Pilkington L; Keegan H; Delamere S; Martin CM; Sheils O; O'Leary JJ; Mulcahy F
Int J STD AIDS; 2015 Oct; 26(11):789-95. PubMed ID: 25258395
[TBL] [Abstract][Full Text] [Related]
47. Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening.
Sargent A; Fletcher S; Bray K; Kitchener HC; Crosbie EJ
BMJ Open; 2019 Apr; 9(4):e025388. PubMed ID: 31036707
[TBL] [Abstract][Full Text] [Related]
48. Clinical Performance of Human Papillomavirus Testing and Visual Inspection With Acetic Acid in Primary, Combination, and Sequential Cervical Cancer Screening in China.
Wang MZ; Feng RM; Wang S; Duan XZ; Li D; Zhang X; Mu R; Qiao Y; Smith JS
Sex Transm Dis; 2019 Aug; 46(8):540-547. PubMed ID: 31295223
[TBL] [Abstract][Full Text] [Related]
49. Prevalence and correlates of cervical squamous intraepithelial lesions among HIV-infected and uninfected women in Central Kenya.
Njagi SK; Ngure K; Mwaniki L; Kiptoo M; Mugo NR
Pan Afr Med J; 2021; 39():44. PubMed ID: 34422167
[TBL] [Abstract][Full Text] [Related]
50. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.
Denny L; Kuhn L; Hu CC; Tsai WY; Wright TC
J Natl Cancer Inst; 2010 Oct; 102(20):1557-67. PubMed ID: 20884893
[TBL] [Abstract][Full Text] [Related]
52. Use of HPV testing in cervical cancer screening services in Mexico, 2008-2018: a nationwide database study.
Hurtado-Salgado E; Ortiz-Panozo E; Salmerón J; Saavedra-Lara N; Kuri-Morales P; Pesqueira-Villegas E; Luna-Gordillo R; Franco EL; Lazcano-Ponce E
Salud Publica Mex; 2018; 60(6):722-733. PubMed ID: 30699277
[TBL] [Abstract][Full Text] [Related]
53. Evaluating the Performance of Hybrid Capture 2 Test as a Primary Screening Test from Studies Conducted in Low and Middle-Income Country Settings- Special Focus India.
Anand KV; Pimple SA; Bhattacharjee A; Mishra GA; Shastri SS
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2709-2716. PubMed ID: 34452578
[TBL] [Abstract][Full Text] [Related]
54. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
Bokan T; Ivanus U; Jerman T; Takac I; Arko D
Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
[TBL] [Abstract][Full Text] [Related]
55. Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.
Keller MJ; Burk RD; Xie X; Anastos K; Massad LS; Minkoff H; Xue X; D'Souza G; Watts DH; Levine AM; Castle PE; Colie C; Palefsky JM; Strickler HD
JAMA; 2012 Jul; 308(4):362-9. PubMed ID: 22820789
[TBL] [Abstract][Full Text] [Related]
56. Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study.
Wu TJ; Smith-McCune K; Reuschenbach M; von Knebel Doeberitz M; Maloba M; Huchko MJ
BMJ Open; 2016 Sep; 6(9):e012547. PubMed ID: 27625065
[TBL] [Abstract][Full Text] [Related]
57. The role of human papillomavirus deoxyribonucleic acid assay and repeated cervical cytologic examination in the detection of cervical intraepithelial neoplasia among human immunodeficiency virus-infected women. Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network.
Cohn JA; Gagnon S; Spence MR; Harrison DD; Kluzak TR; Langenberg P; Brinson C; Stein A; Hellinger J;
Am J Obstet Gynecol; 2001 Feb; 184(3):322-30. PubMed ID: 11228481
[TBL] [Abstract][Full Text] [Related]
58. [Effectiveness and health economic analysis of strategies on cervical cancer screening and early diagnosis and treatment].
Zhao FH; Chen JF; Gao XH; Gao LM; Liu QG; Liu ZH; Xu H; Ma JF; Ma L; Xu XL; Hu SY; Ning Y; Shi JF; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):632-6. PubMed ID: 23159002
[TBL] [Abstract][Full Text] [Related]
59. Randomised study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel.
Gustavsson I; Aarnio R; Berggrund M; Hedlund-Lindberg J; Sanner K; Wikström I; Enroth S; Olovsson M; Gyllensten U
Int J Cancer; 2019 Jan; 144(1):89-97. PubMed ID: 29943822
[TBL] [Abstract][Full Text] [Related]
60. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]